Long-term preservation of kidney function with SGLT-2 inhibitors versus comparator drugs in people with type 2 diabetes and chronic kidney disease.

It should be noted that, while all eGFR‐based secondary outcomes are consistent with the primary endpoint, eGFR‐independent secondary outcomes (e.g., albuminuria‐based ones) are only nominally significant because no adjustment of type I error inflation due to multiple testing was performed, and should therefore be considered exploratory.

also in 7,732 other papers